GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Carl Zeiss Meditec AG (OTCPK:CZMWF) » Definitions » Price-to-Tangible-Book

Carl Zeiss Meditec AG (Carl Zeiss Meditec AG) Price-to-Tangible-Book

: (As of Today)
View and export this data going back to . Start your Free Trial

As of today (2024-04-23), Carl Zeiss Meditec AG's share price is $97.95. Carl Zeiss Meditec AG's Tangible Book per Share of Dec. 2023 for the quarter that ended in Dec. 2023 was $0.00. Hence, Carl Zeiss Meditec AG's Price to Tangible Book Ratio of today is .

The historical rank and industry rank for Carl Zeiss Meditec AG's Price-to-Tangible-Book or its related term are showing as below:

CZMWF' s Price-to-Tangible-Book Range Over the Past 10 Years
Min: 3.26   Med: 4.77   Max: 12.71
Current: 5.89

During the past 13 years, Carl Zeiss Meditec AG's highest Price to Tangible Book Ratio was 12.71. The lowest was 3.26. And the median was 4.77.

CZMWF's Price-to-Tangible-Book is ranked worse than
76.24% of 703 companies
in the Medical Devices & Instruments industry
Industry Median: 2.63 vs CZMWF: 5.89

A closely related ratio is called PB Ratio. As of today, Carl Zeiss Meditec AG's share price is $97.95. Carl Zeiss Meditec AG's Book Value per Sharefor the quarter that ended in Dec. 2023 was $0.00. Hence, Carl Zeiss Meditec AG's P/B Ratio of today is .

Carl Zeiss Meditec AG Price-to-Tangible-Book Historical Data

The historical data trend for Carl Zeiss Meditec AG's Price-to-Tangible-Book can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Carl Zeiss Meditec AG Annual Data
Trend Sep14 Sep15 Sep16 Sep17 Sep18 Sep19 Sep20 Sep21 Sep22 Sep23
Price-to-Tangible-Book
Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 9.93 9.80 13.60 6.85 4.97

Carl Zeiss Meditec AG Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Price-to-Tangible-Book Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - 9.37 - 4.97 -
Competitive Comparison

For the Medical Instruments & Supplies subindustry, Carl Zeiss Meditec AG's Price-to-Tangible-Book, along with its competitors' market caps and Price-to-Tangible-Book data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Carl Zeiss Meditec AG Price-to-Tangible-Book Distribution

For the Medical Devices & Instruments industry and Healthcare sector, Carl Zeiss Meditec AG's Price-to-Tangible-Book distribution charts can be found below:

* The bar in red indicates where Carl Zeiss Meditec AG's Price-to-Tangible-Book falls into.


Carl Zeiss Meditec AG Price-to-Tangible-Book Calculation

Carl Zeiss Meditec AG's price-to-tangible-book ratio for today is calculated as:

Price to Tangible Book=Share Price/Tangible Book per Share (Q: Dec. 2023 )
=97.95/0
=

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

Price to Tangible Book=Market Cap/Tangible Equity
=Market Cap/(Total Stockholders Equity-Preferred Stock-Intangible Assets)

A closely related ratio is called PB Ratio. The difference between Price-to-Tangible-Book Ratio and PB Ratio is that book value other than intangibles are used in the calculation.

Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The Price-to-Book Ratio does not work well for these companies. Some companies even have negative equity, so the Price-to-Book Ratio cannot be applied to them.

Carl Zeiss Meditec AG Price-to-Tangible-Book Related Terms

Thank you for viewing the detailed overview of Carl Zeiss Meditec AG's Price-to-Tangible-Book provided by GuruFocus.com. Please click on the following links to see related term pages.

Carl Zeiss Meditec AG (Carl Zeiss Meditec AG) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Carl Zeiss Meditec AG (OTCPK:CZMWF) » Definitions » Price-to-Tangible-Book
Comparable Companies
XTER:GXI XTER:FIE FRA:PHH2 ISRG XPAR:EL BDX TSE:7741 XSWX:ALC OCSE:COLO B RMD WST XPAR:DIM TSE:4543 XSWX:STMN BAX COO HOLX TSE:7733 TSE:6869 TFX
Traded in Other Exchanges
CZMWY:USA 1AFX:Italy AFXd:UK 0DHC:UK AFX:Germany AFX:Austria
Address
Goschwitzer Strasse 51-52, Jena, TH, DEU, 07745
Website
https://www.zeiss.com
Carl Zeiss Meditec is one of the largest medical technology companies in the world and it operates in two segments: Ophthalmic devices and Microsurgery. OPT, which made up 75% of sales in 2022, includes refractive lasers, surgical ophthalmic devices, equipment for ophthalmic diagnostics, as well as a portfolio of intraocular lenses and disposable medical instruments. With a low-teens share of the market, Zeiss is the second-largest player in the space. MCS is composed of implants, surgical instruments, and visualization devices used during neurosurgery, spine surgery, and otolaryngology surgery. With over 60% market share, Zeiss is the clear leader in the microsurgery space.